Comments
Claris Lifesciences has received approval from the US health regulator for Metoprolol Tartrate injection used for treating angina and hypertension.
The company has received abbreviated new drug application (ANDA) approval from the United States Food and Drug Administration (UDFSA) for Metoprolol Tartrate injection in the strength of 1mg/ml in 5 mg glass vials, Claris Lifesciences today said in a filing to the BSE.
The product is used for treating cardiac conditions such as angina and hypertension. It is also used for treating, or preventing, heart attack.
The company currently has a total 32 ANDA filings with 10 ANDA approvals, Claris Lifesciences said.
Claris Lifesciences is a leading sterile injectables pharmaceutical company having presence in 98 countries.
Shares of Claris Lifesciences were trading at Rs 180.25 apiece on the BSE in the afternoon trade, up 0.81 per cent from their previous close.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.